Long-Cheng LI is the founder of Ractigen Therapeutics. Ractigen Therapeutics has raised $80M in total funding. Latest round: Series A.
Long-Cheng Li is the Co-founder, President, and CEO of Ractigen Therapeutics, a clinical-stage biotech company focused on developing small activating RNA (saRNA) therapeutics. He leads the company's efforts to advance saRNA programs from preclinical to clinical phases.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide